Annual CFF
$1.74 M
-$8.89 M-83.61%
December 31, 2023
Summary
- As of February 7, 2025, LYEL annual cash flow from financing activities is $1.74 million, with the most recent change of -$8.89 million (-83.61%) on December 31, 2023.
- During the last 3 years, LYEL annual CFF has fallen by -$475.05 million (-99.63%).
- LYEL annual CFF is now -99.63% below its all-time high of $476.79 million, reached on December 31, 2020.
Performance
LYEL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$862.00 K-100.00%
September 30, 2024
Summary
- As of February 7, 2025, LYEL quarterly cash flow from financing activities is $0.00, with the most recent change of -$862.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, LYEL quarterly CFF has dropped by -$759.00 thousand (-100.00%).
- LYEL quarterly CFF is now -100.00% below its all-time high of $476.42 million, reached on March 31, 2020.
Performance
LYEL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.65 M
+$143.00 K+9.50%
September 30, 2024
Summary
- As of February 7, 2025, LYEL TTM cash flow from financing activities is $1.65 million, with the most recent change of +$143.00 thousand (+9.50%) on September 30, 2024.
- Over the past year, LYEL TTM CFF has dropped by -$95.00 thousand (-5.45%).
- LYEL TTM CFF is now -99.65% below its all-time high of $476.79 million, reached on December 1, 2020.
Performance
LYEL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LYEL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -83.6% | -100.0% | -5.5% |
| 3 y3 years | -99.6% | -100.0% | -99.6% |
| 5 y5 years | -99.5% | -100.0% | -99.6% |
LYEL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.6% | at low | -100.0% | +100.0% | -99.6% | +9.5% |
| 5 y | 5-year | -99.6% | at low | -100.0% | +100.0% | -99.7% | +31.3% |
| alltime | all time | -99.6% | at low | -100.0% | +100.0% | -99.7% | +31.3% |
Lyell Immunopharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $1.65 M(+9.5%) |
| Jun 2024 | - | $862.00 K(+3092.6%) | $1.50 M(-18.2%) |
| Mar 2024 | - | $27.00 K(-96.4%) | $1.84 M(+5.5%) |
| Dec 2023 | $1.74 M(-83.6%) | $759.00 K(-630.8%) | $1.74 M(-5.6%) |
| Sep 2023 | - | -$143.00 K(-112.0%) | $1.85 M(-72.6%) |
| Jun 2023 | - | $1.20 M(-1833.3%) | $6.75 M(-15.7%) |
| Mar 2023 | - | -$69.00 K(-108.0%) | $8.01 M(-24.7%) |
| Dec 2022 | $10.63 M | $863.00 K(-81.9%) | $10.63 M(-38.1%) |
| Sep 2022 | - | $4.76 M(+93.7%) | $17.17 M(+44.5%) |
| Jun 2022 | - | $2.46 M(-3.8%) | $11.88 M(-97.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $2.56 M(-65.5%) | $402.92 M(+0.4%) |
| Dec 2021 | $401.24 M(-15.8%) | $7.40 M(-1493.4%) | $401.24 M(+1.8%) |
| Sep 2021 | - | -$531.00 K(-100.1%) | $394.18 M(-0.1%) |
| Jun 2021 | - | $393.49 M(>+9900.0%) | $394.75 M(>+9900.0%) |
| Mar 2021 | - | $884.00 K(+161.5%) | $1.25 M(-99.7%) |
| Dec 2020 | $476.79 M(+35.8%) | - | - |
| Dec 2020 | - | $338.00 K(+865.7%) | $476.79 M(+0.1%) |
| Sep 2020 | - | $35.00 K(-1850.0%) | $476.45 M(+0.0%) |
| Jun 2020 | - | -$2000.00(-100.0%) | $476.42 M(-0.0%) |
| Mar 2020 | - | $476.42 M | $476.42 M |
| Dec 2019 | $351.16 M | - | - |
FAQ
- What is Lyell Immunopharma annual cash flow from financing activities?
- What is the all time high annual CFF for Lyell Immunopharma?
- What is Lyell Immunopharma annual CFF year-on-year change?
- What is Lyell Immunopharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly CFF year-on-year change?
- What is Lyell Immunopharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lyell Immunopharma?
- What is Lyell Immunopharma TTM CFF year-on-year change?
What is Lyell Immunopharma annual cash flow from financing activities?
The current annual CFF of LYEL is $1.74 M
What is the all time high annual CFF for Lyell Immunopharma?
Lyell Immunopharma all-time high annual cash flow from financing activities is $476.79 M
What is Lyell Immunopharma annual CFF year-on-year change?
Over the past year, LYEL annual cash flow from financing activities has changed by -$8.89 M (-83.61%)
What is Lyell Immunopharma quarterly cash flow from financing activities?
The current quarterly CFF of LYEL is $0.00
What is the all time high quarterly CFF for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly cash flow from financing activities is $476.42 M
What is Lyell Immunopharma quarterly CFF year-on-year change?
Over the past year, LYEL quarterly cash flow from financing activities has changed by -$759.00 K (-100.00%)
What is Lyell Immunopharma TTM cash flow from financing activities?
The current TTM CFF of LYEL is $1.65 M
What is the all time high TTM CFF for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM cash flow from financing activities is $476.79 M
What is Lyell Immunopharma TTM CFF year-on-year change?
Over the past year, LYEL TTM cash flow from financing activities has changed by -$95.00 K (-5.45%)